Description

This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) captures insights across recent advances in life science, health & wellness. Key advances across liquid biopsy and cancer management have been included. The TOE also analyzes exciting device and therapeutic innovations for the management of neurodegenerative and cardiovascular disorders. Furthermore, the TOE examines recent advances across digital and artificial intelligence-based platforms for healthcare.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Liquid biopsy, cancer, artificial intelligence, drug design, digital health, cochlear, GN Hearing, hearing aid, Android Streaming, blood draw, HbA1C, neuromodulation, neurodegeneration, drug discovery, neuroscience, synapse, genomics, biomarkers, neuroscience, non-invasive therapy, venous disease, aneurysm, sepsis, ADHD, upper-limb neuromuscular disorder, CorInnova, heart failure, robotic, ARTIDIS, biopsy, microscope, histopathology, automated processing, lung disease, glioblastoma, Biobeat, patient monitoring, ulcerative colitis, pancreatic cancer, deep brain stimulation, Parkinson's Disease, macular degeneration, Angelman syndrome